company logo

SOCIETY FOR INVESTIGATIVE DERMATOLOGY

Honorary Members

Any distinguished physician or research scientist may be elected an honorary member of the SID. Candidates for honorary membership are nominated annually by a committee of active members.

H. Baden   L. Goldsmith   S. Pinnell*
E. Bauer   R. Goltz   M. Prunieras
P. Bergstresser   M. Greaves   W. Quevedo, Jr
E. Beutner   H. Green   H. Rorsman
D. Bickers   J. Grupenhoff   W. Shelley
O. Braun-Falco   G. Hambrick, Jr.* S. Shimada
I. Braverman   J. Hanifin   B. Shroot
A. Breatnach   F. Hu*   S. Shuster
R. Briggaman   Y. Ishibashi   F. Snyder*
W. Bullough*   S. Jablonska D. Stevanovic
H.D. Chen   R. Jordon G. Stingl
L. H. Chiung   S. Katz   J. Strauss*
E. Christophers   A. Kligman*   H. Tagami
R. Clark   K. Kraemer N. Thyresson
H. Davidson*   G. Krueger   M. Turner
R. Degos   A. Kukita J. Uitto
L.  Diaz   C. Lapiere   E. Van Scott
R. Dobson   G. Lazarus   J. Voorhees
R. Eady   A. Lerner* P. Weary*
A. Eisen   J. Leyden G. Weinstein
A. ElMofty   W. Lobitz, Jr.* C. Wheeler, Jr.*
R. Edelson I. Magnus* K. Wolff
P. Elias Y. Mishima K.L. Yang
E. Epstein, Jr. T. Nishikawa S. Yuspa
J. Fernandez   D. Norris      
I. Freedberg*   S. Ofuji      
R. Freinkel* H. Ogawa      
I. Gigli C. Orfanos      
B. Gilchrest   J. Parrish      
Honorary Membership is one of the highest honors our Society can bestow.  

We are pleased to announce and congratulate our newest members.

 
 
Richard Edelson, MD, has served continuously as Chairman of the Department of Dermatology at Yale since 1986. He also served as Director of the Cancer Center, Deputy Dean for Clinical Affairs, and Director of the Cancer Center’s Lymphoma Research Program. He invented Photopheresis, which has been used on thousands of patients since its discovery. Dr. Edelson is an internationally recognized pioneer in the research and treatment of Cutaneous T-cell Lymphoma (CTCL) and immunogenic cancers, and has served as a mentor to countless young investigators.
 
Peter M. Elias, MD is a Professor in the Department of Dermatology at the University of California San Francisco, and a Staff Physician at the Veterans Affairs Medical Center, San Francisco. Dr. Elias has authored or co-authored over 550 peer-reviewed scientific articles, innumerable review articles, and he has edited or co-authored three books on the subject of the skin barrier in health and disease. He has served to accelerate discovery in his own research, and via his collaborations with Industry.
 
John Parrish, MD, is the Chief Executive Officer and co-founder of the Center for the Integration of Medicine and Innovative Technology (CIMIT), a consortium of academic and engineering research laboratories, universities and more than 40 private-sector companies. His work has advanced the standards of care for all patients through the development and the adoption of targeted medical devices and technologies.  He successfully developed new therapies to treat skin disease, including the now-common use of ultraviolet light. For two decades, Dr. Parrish served as Chief of the Department of Dermatology at Massachusetts General Hospital, founding the Wellman Center for Photomedicine.
Each of these individuals has made sustained and important contributions to the research base in cutaneous biology and has contributed to the organizational success of the SID. Each has also excelled in their role as a mentor to numerous individuals over the course of their academic career.